| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/07/2007 | CN1298739C Anti-bacterial agent |
| 02/07/2007 | CN1298717C Quinuclidine carbamate derivatives and their use as M3 antigonists |
| 02/07/2007 | CN1298707C Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 02/07/2007 | CN1298389C Compound preparation of calcium antagonist and timishatan for reducing blood pressure and its use |
| 02/07/2007 | CN1298332C Medicine composition comprising arsenite for treatment of malignancy |
| 02/07/2007 | CN1298330C Self-administered contraceptive injection of oily solution |
| 02/07/2007 | CN1298321C Use of phototoxicity control object of preparing medicine for restraining phototoxicity by ultraviolet radiation |
| 02/07/2007 | CN1298314C Stable salts of O-acetylsalicylic acid containing basic amino acids II |
| 02/06/2007 | US7173115 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of cancer |
| 02/06/2007 | US7173109 Peptide sequence derived from the ghrelin polypeptide, coupled to a cystine amino acid, labeled with a fluorescent dye; used in high throughput screening to identify and characterize cellular receptors |
| 02/06/2007 | US7173037 Compounds for trearment of cardiovascular disorders and hypotensive agents |
| 02/06/2007 | US7173020 Anticancer agents and drug delivery agents with nucleotides |
| 02/06/2007 | US7173017 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 02/06/2007 | US7172892 Exhibit protease activity as a single chain or as an activated two chain form; use of polypeptides to identify compounds that modulate the protease activity thereof and as tumor markers |
| 02/06/2007 | US7172871 Methods and compositions for modulating axonal outgrowth of central nervous system neurons |
| 02/06/2007 | US7172769 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
| 02/06/2007 | US7172767 Opioid agonist / antagonist combinations |
| 02/06/2007 | US7172763 Post-operative pain treatment by peripheral administration of a neurotoxin |
| 02/06/2007 | US7172760 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots |
| 02/06/2007 | US7172752 Synergistic mixture of antiserotonine agents and glucocorticoids; inhalation |
| 02/06/2007 | CA2362816C Valdecoxib compositions |
| 02/06/2007 | CA2132507C Method for altering hair growth and compositions used therefore |
| 02/01/2007 | WO2007013696A1 Anti-tumor agent comprising 6'-amidino-2'-naphthyl4- guanidinobenzoate or salt thereof |
| 02/01/2007 | WO2007013677A1 Potentiator for substance having interferon-like effect |
| 02/01/2007 | WO2007013613A1 Composition containing fucoidan or fucoidan hydrolysate and immunopotentiating material |
| 02/01/2007 | WO2007013593A1 Method for diagnosis of gastric cancer utilizing methylation of novel gene acmg1 as index |
| 02/01/2007 | WO2007013494A1 Drug containing phosphate ion as blood glucose level-controlling agent |
| 02/01/2007 | WO2007012841A2 Compositions comprising monobutyrin |
| 02/01/2007 | WO2007012837A2 Compositions for treating psychiatric conditions |
| 02/01/2007 | WO2006134160A3 Synergistic mixtures of aromatic alcohols and derivatives thereof and tropolone (derivatives) |
| 02/01/2007 | WO2005123055A3 Methods for treating inflammatory disorders |
| 02/01/2007 | US20070028315 DNA encoding SNORF33 receptor |
| 02/01/2007 | US20070027212 3-Aminomethyl-5-methyl-octanoic acid; antidepressant and anxiolytic agent; obsessive compulsive disorder (OCD), agoraphobia, agoraphobia without history of panic disorder, specific phobia, social phobia, restless legs syndrome, premenstrual dysphoric disorder, hot flashes, and fibromyalgia; not addictive |
| 02/01/2007 | US20070027197 Pharmaceutical composition and method for the treatment of diseases using HMG-CoA reductase inhibitors and insulin secretion enhancers or sensitizers |
| 02/01/2007 | US20070027167 Use of c-Src inhibitors alone or in combinaton with STI571 for the treatment of leukaemia |
| 02/01/2007 | US20070027129 Taxane, magnetic moiety and covalent binder for production of magnetic antimitotic agent with higher toxicity to cancer cells than normal cells |
| 02/01/2007 | US20070027127 Treatment of inflammatory oral diseases with a combination of inhibitors of TNF-alpha and immunosuppressive agents |
| 02/01/2007 | US20070027124 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 02/01/2007 | US20070027123 Administering an estrogen receptor for treatment of osteoporosis, breast cancer, hypercholesteremia, hyperlipidemia or artheriosclerosis by administering estrogen modulators |
| 02/01/2007 | US20070027122 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 02/01/2007 | US20070027120 Intermittent administration allows high doses of vitamin D compounds (calcitrol) to be administered while minimizing or eliminating hypercalcemia |
| 02/01/2007 | US20070027101 Treating ocular neovascular disease using anti-VEGF therapy in combination with a second therapy that inhibits the development of ocular neovascularization or destroys abnormal blood vessels in the eye, such as photodynamic therapy |
| 02/01/2007 | US20070027093 Anorectic |
| 02/01/2007 | US20070027090 Methods of treating cognitive dysfunction by modulating brain energy metabolism |
| 02/01/2007 | US20070026515 Cell or drug encapsulation device having a wet seal |
| 02/01/2007 | US20070026450 Methods for the treatment of carcinoma |
| 02/01/2007 | US20070026449 Novel human sodium-dependent phosphate cotransporter |
| 02/01/2007 | US20070026422 Vaccine-induced hepatitis B viral strain and uses thereof |
| 02/01/2007 | US20070026389 Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| 02/01/2007 | US20070026091 Preparation and Administration of Jojoba Product for Reducing Weight, Fat and Blood Lipid Levels and for the Prevention and Treatment of Cancer |
| 02/01/2007 | US20070026054 Medicament preparations for transdermal application containing active ingredient combinations for treating parkinson's disease |
| 02/01/2007 | US20070026036 Drug/Drug Delivery Systems for the Prevention and Treatment of Vascular Disease |
| 02/01/2007 | US20070026001 APO-2 ligand-anti-her-2 antibody synergism |
| 02/01/2007 | US20070026000 APO-2L receptor agonist and CPT-11 synergism |
| 02/01/2007 | US20070025999 Treatment with anti-vegf antibodies |
| 02/01/2007 | US20070025998 Methods for enhancing the efficacy of cancer therapy |
| 02/01/2007 | US20070025993 Tek antagonists |
| 02/01/2007 | US20070025989 Administration of agents for the treatment of inflammation |
| 02/01/2007 | US20070025971 Substances causing differentiation |
| 02/01/2007 | US20070025927 Odorless formulation for treating mucosal discontinuities |
| 02/01/2007 | US20070025913 Immunoglobulin which specifically binds endothelial cell-specific polypeptides; for use as evaluative tool in immunodiagnostic and drug efficacy studies |
| 02/01/2007 | DE10301917B4 Verwendung von Substanzen der Porphyrinsynthese bei der Phototherapie von Haut- oder Gelenkerkrankungen des Menschen oder von Säugetieren Use of substances of the porphyrin synthesis in the phototherapy of skin or joint disease of humans or mammals |
| 02/01/2007 | CA2617219A1 Compositions comprising fucoidan or a fucoidan hydrolysate and an immuno-stimulating material |
| 02/01/2007 | CA2616534A1 Antitumor agent comprising 6'-amidino-2'-naphthyl4- guanidinobenzoate or salt thereof |
| 02/01/2007 | CA2616386A1 Single dose use of cd20-specific binding molecules |
| 01/31/2007 | EP1747800A1 Combination of itriglumide and proton pump inhibitors in the treatment of gastrointestinal and related disorders |
| 01/31/2007 | EP1747778A1 Antifatigue composition |
| 01/31/2007 | EP1747017A2 Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration |
| 01/31/2007 | EP1747016A2 Use of dipyridamole for treatment of resistance to platelet inhibitors |
| 01/31/2007 | EP1746995A1 Method of using and compositions comprising immunomodulatory compounds for the treatment and management of myeloproliferative diseases |
| 01/31/2007 | EP1746989A1 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases |
| 01/31/2007 | EP1746986A1 Active substance combination comprising a carbinol combined to at least an nsaid |
| 01/31/2007 | EP1746888A2 Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 01/31/2007 | EP1746885A1 Agonists of a2a adenosine receptors for treatment of diabetic nephropathy |
| 01/31/2007 | EP1746882A2 Methods for treating blood disorders with nitric oxide donor compounds |
| 01/31/2007 | EP1478357B1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 01/31/2007 | EP1365749B1 Process for preparing pharmaceutical compositions for use with soft gelatin formulations |
| 01/31/2007 | EP1303541A4 Gel compositions containing metronidazole |
| 01/31/2007 | EP1194138B1 Nutritional supplements |
| 01/31/2007 | EP1052999B1 Chelated 8-hydroxyquinoline for the treatment of epithelial lesions |
| 01/31/2007 | CN1906214A Anti-IGFR1 antibody therapeutic combinations |
| 01/31/2007 | CN1905921A Local intraosseous administration of bone forming agents and anti-resorptive agents and devices therefor |
| 01/31/2007 | CN1905902A Novel combination of anticholineric and beta mimetics for the treatment of respiratory diseases |
| 01/31/2007 | CN1905901A Erythrocyte function modifying substance |
| 01/31/2007 | CN1905896A Methods of enhancing immune response in the intradermal compartment and compounds useful thereof |
| 01/31/2007 | CN1905889A A medical solution, a method for producing said medical solution and use thereof |
| 01/31/2007 | CN1903365A Drug-carried nanometer particles, and its preparing process for preparing medicien prepn. for anti-restenosis of blood-vessel |
| 01/31/2007 | CN1903364A Medicine composition contg. inhibitor of angiotonase and phenoxy acid compounds |
| 01/31/2007 | CN1903189A Medicine composition contg. Tamsulosin and calcium antagonist |
| 01/31/2007 | CN1903179A Preparing method of powder agglomerates |
| 01/31/2007 | CN1297653C Composition comprising a lactobacillus pentosus strain and uses thereof |
| 01/31/2007 | CN1297601C Modified starch film compositions and uses thereoof |
| 01/31/2007 | CN1297566C DNA for encoding the RGI polypeptide |
| 01/31/2007 | CN1297555C Antagonists of MCP-q function and method of use thereof |
| 01/31/2007 | CN1297319C Preparing pharmaceutics of medication containing antimicrobials by using silicone oil as medium |
| 01/31/2007 | CN1297317C Treatment of viral infections |
| 01/31/2007 | CN1297281C Method for treatment of leukaemia |
| 01/31/2007 | CN1297258C EPO D+5-fu/gemcitabine |
| 01/30/2007 | US7169815 3-methoxybenzyl thiourea derivatives and improved lipid compositions containing same |
| 01/30/2007 | US7169777 Melanocortin receptor agonists |